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Objective: Intraabdominal adhesion is a frequently encountered condition after surgery and can end up
in important complications. The objective of this study is to test whether the antiadhesiogenic effect of
heparin could be antagonized by administration of protamine in a rat model.
Material and methods: A laparotomy with caecal abrasion model was used in 40 Wistar rats. Single dose
of 1 cc saline was injected subcutaneously (SC) in one group (control); 50 IU/kg heparin was injected SC
in Group 2; 50 IU/kg protamine SC given to Group 3; 50 IU/kg heparin and 50 IU/kg protamine was given
SC to Group 4 for 3 consecutive days. Each group consisted of 10 rats. All rats were sacriﬁced one week
later for macroscopic and microscopic examination and they were scored for adhesion using Mazuji
adhesion scale.
Results: There was signiﬁcant difference in the heparin group with respect to Mazuji adhesion score,
histopathological score (ﬁbrosis, inﬂammation and vascular proliferation) and S-100 staining (P < 0.05).
Additionally, the inﬂammation was more severe in the mucosa and submucosa compared to serosa in the
heparin group (P < 0.01). With respect to ﬁbrosis and vascular proliferation, apart from submucosal
ﬁbrosis, heparin group was statistically superior to the control group by means of each layer (P < 0.01).
Conclusion: It seems that heparin is effective preventing adhesion in this rat model. Abolition of hepa-
rin's antiadhesiogenic effect by protamine administration is likely exerted via its antithrombine activity.
Clinical application of our ﬁndings in intraabdominal surgery warrants further investigation.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Postsurgical intraperitoneal adhesions may pose important
problems for the patient and the surgeon as well and theirAras¸tırma Hastanesi, Genel
.
by Elsevier Ltd. All rights reservedmanagement might become pretty much costly to the community.
Their physiopathology is characterized by a cascade triggered by
injury and composed of coagulation, inﬂammation and prolifera-
tion that end up in ﬁbrin generation and eventual establishment of
adhesions in the peritoneal cavity. Thus, its prevention is thought to
be possible via reducing inﬂammation and increasing anticoagu-
lant activity of the intraperitoneal cavity [1e3]. Postoperative
abdominal adhesions are seen in 95% of patients after surgery and
the rate of re-hospitalization because of those adhesions is reported.
Fig. 1. Establishment of adhesion model (before and after).
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light abdominal pain, although occasionally they may lead to
obstruction of the bowel or even sometimes of upper urinary tract
and they sometimes can be a cause infertility in women as well
[6,7].
Heparin use is indicated in the treatment and prophylaxis of
venous thrombosis, pulmonary embolism, pectoral angina and
acute myocardial infarction, coronary by-pass, vascular surgical
procedures, coronary angioplasty, stent applications and in some
selected disseminated intravascular coagulation. Main indication to
use heparin is its anticoagulation and antithrombotic effects which
are exerted via its antithrombine character. Heparin inhibits
thrombin, factors Xa, IXa, Xia and XIIa activities [8,9]. On the other
hand, protamine sulfate is an antagonist of heparin and it works by
cleaving heparin from antithrombine [10].
In this study, we aimed studying heparin's anti-adhesiogenic
effects by inhibition of its activity using protamine sulfate.
2. Material and methods
Experimental protocol was approved by the Ethical Board of
Marmara University Experimental Animal Research Center
(DEHAMER) (5/27/2013, #39.2012.Mar). Forty female rats weighed
between 180 and 220 g were obtained from DEHAMER. They were
fasted for 12 h and thenweighed and theywere anesthetized using a
combination of intramuscular 3e5 mg chloropromazine (Largactil®
25 mg/5 ml amp Eczacıbas¸ı, Istanbul, Turkey) and 100 mg/kg keta-
mine (Ketalar®500 mg ﬂc; Pﬁzer, Istanbul, Turkey). Surgical pro-
cedures were performed with sterile technique. Once general
anesthesia induced the abdominal region was cleaned using 7.5%
povidone iodine soap (Polyod®) and saline, the areawas then shaved
and stained with 1% povidone iodine and a laparotomy was done
aseptically via 3 cm median incision. Cecum was then found and
abrasion was performed onto the cecum by rubbing the surface for
10 times at a 1 cm square surface using dental ﬂoss, until subserosal
ecchymosis obtained. Subsequently the abdomen was closed using
continuous 3/0 silk suture and the surgery was ended. Afterward,
four experimental groups were deﬁned, each including 10 rats and
the following treatments were performed subcutaneously (SC) for
three days to each group starting two hours after the surgery:
- Group 1 (control group) (n ¼ 10) SC saline,
- Group 2 (n ¼ 10) SC 50 IU/kg heparin (Nevparin 25,000 IU/5 ml
ﬂacon, Mustafa Nevzat, Istanbul, Turkey),- Group 3 (n¼ 10) SC 50 IU/kg protamine (Protamine ICN 5000 IU/
5 ml ampoules, MEDA, Istanbul, Turkey),
- Group 4 (n¼ 10) SC 50 IU/kg heparinþ 50 IU/kg protaminewere
administered [11].
During this period, all rats were housed in single cages in a room
with controlled temperature (22 ± 2 C), humidity (50 ± 5%), and a
12-h cycle of light and dark. They were fed laboratory pellet chows
and water was given ad libitum. The evaluation of the general
condition, food intake, and postoperative movements of rats
showed that there was no need of additional analgesic
administration.
Seven days after surgical intervention the rats were blindly
sacriﬁced by cervical dislocation and their abdomenwas opened in
a U shape incision and it was carefully examined. The presence or
absence of ascites, intestinal dilatation, hematoma and intestinal
obstruction were checked. Adhesion and ﬁbrotic areas were also
recorded (Fig. 1) and they were scored based on Mazuji classiﬁca-
tion [12], which is grade-0: No adhesion; grade-1: very small,
irregular adhesion; grade-2: easily separable, moderately rigid
adhesion, grade-3: hard and hardly separable regular adhesion;
grade-4: Very hard, too hard to separate, homogenous adhesion.
Finally, the cecumwas excised with the ﬁbrotic area and they were
sent for microscopical evaluation.
Histopathological evaluation was performed by one pathologist
and histopathological scoring was performed based on ﬁbrosis,
inﬂammation, vascular proliferation and the depth into bowel wall
(mucosa, submucosa and serous layers) (Fig. 2). Furthermore a
staining with S100 was performed to rule out neural staining
[9,10]. Fibrosis was scored as follows: 0: no ﬁbrosis, 1: minimal,
loose ﬁbrosis, 2: medium degree ﬁbrosis, 3: dense ﬁbrosis.
Inﬂammation was scored as follows: 0: no inﬂammation, 1: exis-
tence of giant cells, occasional lymphocytes and plasmocytes, 2:
giant cells, plasma cells, eosinophil and neutrophils, 3: various
inﬂammatory inﬁltrates and microabscesses. Vascular proliferation
was scored as follows: 0: no vascular proliferation, 1: light vascular
proliferation, 2: medium vascular proliferation, 3: severe vascular
proliferation.
2.1. Statistics
ManneWhitney U test was used for 2 group comparisons,
whereas KruskaleWallis H and KruskaleWallis H with Bonferroni
correction were used for comparison of 3 or more groups between
Fig. 2. A: Regular colonic mucosa, light inﬂammation and accompanying increase in the connective tissue in the peripheral fatty tissue extending into the ﬁbers of muscularis
propria (H&Ex100). B: Masson's trichrome staining of the same ﬁeld shows increase in connective tissue in the fatty tissue (masson trikromx100). C: Severe inﬂammation (scored as
grade 3) in the fatty tissues consisted of severe inﬁltration of lymphocytes, polymorphs and histiocytes, other colonic layers look well arranged (H&Ex100). D: s100 positive staining
at the nerve cuts and also at the severe inﬂammatory areas in this immunohistochemically prepared specimen (s100x100).
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Fisher's exact test. A P < 0.05 and in two group comparisons a
P < 0.01 were considered signiﬁcant.
3. Results
No rat mortality was observed. At the exploratory laparotomies
minimal ascites was seen only in group 1 and 2 rats, whereas no
bowel dilation, no hematoma and no bowel obstruction were
recorded. Scoring for adhesion is shown in the Table 1. There was
statistically signiﬁcant difference between control group and hep-
arin group compared to others (P ¼ 0.006 and when group 1 and 2
compared, P ¼ 0.001). With respect to adhesion rates, there was a
difference between control group and group 2 (P¼ 0.005), however
no difference was found between control group and groups 3 and 4
(P ¼ 0.582). As for S100 staining, there was a difference between
control group and group 2 (P ¼ 0.021), but no difference observed
between control group and groups 3 and 4 (P > 0.05).
Histopathological evaluation, ﬁbrosis, inﬂammation and
vascular proliferation and their statistical comparisons are sum-
marized in Table 2. Total Histopathological Score for each rat wasTable 1
Adhesion scoring, rating and S100 staining in all groups.
Group Rat number Adhesion score
0 1 2
1-Control group 10 1 3 4
2-Heparin group 10 8 2 0
3-Protamine group 10 3 3 2
4-Heparin þ protamine group 10 3 5 1
P value P ¼ 0.006 < 0.05
1e2 ¼ 0.001, 1e3 ¼ 0.389
1e4 ¼ 0.096
2e3 ¼ 0.015, 2e4 ¼ 0.022
3e4 ¼ 0.578
Bold characters point to statistically signiﬁcant values.calculated as “inﬂammationþ ﬁbrosisþ vascular proliferation” and
it was found 5.3, 2.4, 5.9 and 5.4 for groups 1,2,3,4 respectively.
Therefore Total Histopathological Score was found to be signiﬁ-
cantly lower in group 2 (P¼ 0.0001). With respect to inﬂammation,
the mucosal and submucosal inﬂammation was found to be lower
in the heparin group compared to others (P ¼ 0.0001), but there
was no difference in serosal inﬂammation between groups
(P > 0.01). A “total inﬂammation score”was calculated for every rat
by summing mucosal þ submucosalþ serosal inﬂammation scores,
and that was found to be 5.0 in group 1; 1.6 in group 2, 4.5 in group
3 and 4.5 in group 4 respectively. These scores show that inﬂam-
mation is signiﬁcantly lower in group 2 compared to others.
Furthermore, with respect to ﬁbrosis and vascular proliferation,
apart from submucosal ﬁbrosis, heparin group was statistically
superior to the control group by means of each layer (P < 0.01);
mucosal, submucosal and serosal layers (Table 3).
4. Discussion
The use of barriers and pharmacological agents in the research
aiming to decrease adhesion formation are mainly based on threeAdhesion rate (%) Staining w. S100
3 4
2 0 9/10 (90) 7
0 0 2/10 (20) 1
2 0 7/10 (70) 8
1 0 7/10 (70) 7
P ¼ 0.005 P ¼ 0.021
Table 2
Histopathological evaluation of adhesion ﬁeld.
Histological
feature
Group Score P value and group
comparisons
0 1 2 3
Inﬂammation Group 1 0 2 4 4 P ¼ 0.004 < 0.05
1e2 ¼ 0.004, 1e3 ¼ 0.168
1e4 ¼ 0.511, 2e3 ¼ 0.007
2e4 ¼ 0.006, 3e4 ¼ 0.453
Group 2 2 6 2 0
Group 3 0 2 8 0
Group 4 0 2 6 2
Fibrosis Group 1 1 4 3 2 P ¼ 0.011 < 0.05
1e2 ¼ 0.021, 1e3 ¼ 0.339
1e4 ¼ 0.781, 2e3 ¼ 0.002
2e4 ¼ 0.013, 3e4 ¼ 0.497
Group 2 5 4 1 0
Group 3 0 3 4 3
Group 4 0 2 4 4
Vascular
proliferation
Group 1 1 3 6 0 P ¼ 0.002 < 0.05
1e2 ¼ 0.031, 1e3 ¼ 0.055
1e4 ¼ 0.671, 2e3 ¼ 0.001
2e4 ¼ 0.009, 3e4 ¼ 0.154
Group 2 3 5 1 0
Group 3 0 1 7 2
Group 4 0 5 4 1
Bold characters point to statistically signiﬁcant values.
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coagulation and increasing ﬁbrinolytic. Despite that a lot of
research is conducted in this ﬁeld, their clinical applications remain
to be very limited. A lot of chemicals or pharmaceutical agents have
been used in preventing intraabdominal adhesions. Some of them
are phosphatidylcholine, heparin, tissue plasminogen activator (t-
PA), ankaferd, nadroparine calcium (low molecular weight heparin
or LMWH), aprotinine, nonsteroid anti-inﬂammatory agents, cor-
ticosteroids, antihistaminics, carboxymethylcellulose, hyaluronic
acid derivatives and barriers like Sepraﬁlm… etc. [13e21].
Adhesion formation is a multifactorial process; although we
focused mainly on its two aspects, namely on anticoagulation and
on antithrombotic effects. Various pharmaceutical agents and/or
anticoagulants have been used either intraperitoneally or subcu-
taneously in previous studies to decrease adhesion formation and
some of those studies found heparin to be effective but some of
them not [15,20,22], whereas we decided to use it systemically.Table 3
Depth of inﬂammation, ﬁbrosis and vascular proliferation according to bowel layer and
Inﬂammation
0 1 2 3
Mucosal score Group 1 2 6 2 0
Group 2 9 1 0 0
Group 3 0 10 0 0
Group 4 0 10 0 0
Submucosal score Group 1 0 4 4 2
Group 2 7 3 0 0
Group 3 0 5 5 0
Group 4 0 6 4 0
Serosal score Group 1 0 2 4 4
Group 2 2 5 3 0
Group 3 0 2 8 0
Group 4 0 2 6 2
Mucosa (P value and group comparisons) P ¼ 0.0001 < 0.05
1e2 ¼ 0.002 < 0.01;
1e3 ¼ 1 > 0.01; 1e4 ¼ 1 > 0.01
2e3; 2e4 ¼ 0.0001 < 0.01;
3e4 ¼ 1 > 0.01
Submucosa (P value and group comparisons) P ¼ 0.0001 < 0.05
1e2 ¼ 0.0001 < 0.01;
1e3 ¼ 0.403; 1e4 ¼ 0.241 > 0.01
2e3, 2e4 ¼ 0.001 < 0.01;
3e4 ¼ 0.661 > 0.01
Serosa (P value and group comparisons) P ¼ 0.021 < 0.05
1e2 ¼ 0.015; 1e3 ¼ 0.510 > 0.01
1e4 ¼ 0.744; 2e3 ¼ 0.017 > 0.01
2e4 ¼ 0.013; 3e4 ¼ 0.737 > 0.01
Bold characters point to statistically signiﬁcant values.Since heparin's adhesion decreasing effect could be linked to its
anti-inﬂammatory effects [23], we decided only to investigate its
effects on adhesion and ﬁbrin formation by manipulating its
antithrombogenic effects using protamine.
Although there are several successful and detailed scoring sys-
tems used for extent and severity of adhesion in literature [24] we
preferred to use Mazuci MK et al. scoring system (12). We believe
that the scoring system of Mazuci MK et al. was also simple and
extensive enough.
Inﬂammation, ﬁbrosis and vascular proliferation are the main
aspects of adhesion formation and/or tissue repair [25]. In our
study, score of inﬂammation, ﬁbrosis and neovascularization was
signiﬁcantly lower in heparin group compared to other groups
(P < 0.05), whereas the same score was high in the protamine
group, implying antagonistic effect of protamine to heparin in the
last group.
Regarding the degree of inﬂammation in colonic wall layers, we
noticed that heparin was effective decreasing inﬂammation in the
mucosal and submucosal layers but not in the serosal layers. This
was surprising to us because our model constituted of serosal
injury to the cecum and we expected more inﬂammation in the
serosal layers. Actually, in a study investigating the effect of
Ankafert Blood Stopper (ABS) on peritoneal adhesions, Comert M
et al. [16], reported less adhesion formation but surprisingly higher
degree of serosal inﬂammation in the ABS group. Even though there
was no report or data about ﬁbrosis and vascular proliferation
scoring system according to layers in our literature research,
ﬁbrosis and vascular proliferation was investigated for each layer;
mucosal, submucosal and serosal layers. Apart from submucosal
ﬁbrosis, heparin group was statistically superior to the control
group by means of each layer.
The results of this study encouraged us to reconsider heparin's
indications in the current surgical practice. Currently, it is well
known that heparin and its derivatives is recommended andwidely
used in the perioperative prophylaxis of venous thromboembolismits scoring.
Fibrosis Vascular proliferation
0 1 2 3 0 1 2 3
7 3 0 0 5 5 0 0
10 0 0 0 9 1 0 0
4 6 0 0 0 10 0 0
8 2 0 0 4 6 0 0
4 3 2 1 1 5 4 0
6 4 0 0 6 3 1 0
2 3 3 2 0 5 4 1
4 5 1 0 1 7 1 1
1 4 3 2 1 4 5 0
5 4 1 0 2 7 1 0
0 3 4 3 0 1 7 2
1 3 4 2 0 3 6 1
P ¼ 0.027 < 0.05
1e2 ¼ 0.067; 1e3 ¼ 0.189 > 0.01;
1e4 ¼ 615 > 0.01;
2e3 ¼ 0.004 < 0.01;
2e4 ¼ 0.146; 3e4 ¼ 0.075 > 0.01.
P ¼ 0.001 < 0.05
1e2 ¼ 0.057; 1e3 ¼ 0.012 > 0.01;
1e4 ¼ 0.661 > 0.01;
2e3 ¼ 0.000 < 0.01;
2e4 ¼ 0.022; 3e4 ¼ 0.029 > 0.01.
P ¼ 0.084 > 0.05 P ¼ 0.014 < 0.05
1e2 ¼ 0.022; 1e3 ¼ 0.426 > 0.01;
1e4 ¼ 0.546 > 0.01;
2e3 ¼ 0.005 < 0.01;
2e4 ¼ 0.038; 3e4 ¼ 0.168 > 0.01.
P ¼ 0.011 < 0.05
1e2 ¼ 0.021; 1e3 ¼ 0.339; 0.01;
1e4 ¼ 0.781 < 0.01;
2e3 ¼ 0.002 > 0.01;
2e4 ¼ 0.013; 3e4 ¼ 0.497 < 0.01.
P ¼ 0.002 < 0.05
1e2 ¼ 0.084; 1e3 ¼ 0.028 > 0.01;
1e4 ¼ 0.235 > 0.01;
2e3 ¼ 0.001 < 0.01;
2e4 ¼ 0.006 < 0.01;
3e4 ¼ 0.264 > 0.01.
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perioperative surgery could be extended in terms of its anti-
adhesiogenic effects besides its traditional antithrombotic use.
In conclusion, it seems that heparin is effective in this adhesion
model in rats. The protamine's antagonizing effect suggests that
heparin's antiadhesiogenic effect is carried out via antitrombine III.
As a result, we think that the clinical use of heparin could be
expanded in terms of its antiadhesiogenic effects while it is clini-
cally being used for its anticoagulation and antithrombogenic ef-
fects at perioperative period.
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